CUI1 stringlengths 8 8 | RELA stringlengths 3 54 | CUI2 stringlengths 8 8 | Name1 stringlengths 1 2.86k ⌀ | Name2 stringlengths 1 2.86k ⌀ | Def1 stringlengths 1 8.95k ⌀ | Def2 stringlengths 1 8.95k ⌀ |
|---|---|---|---|---|---|---|
C0000379 | has_component | C5825312 | 3,4-Methylenedioxyamphetamine | methylenedioxyamphetamine in serum or plasma by confirmatory method | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C0801397 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnc:Pt:Urine:Qn | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C0801401 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnc:Pt:Bld:Qn | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C0802439 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:PrThr:Pt:Urine:Ord:Screen | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C0802440 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:PrThr:Pt:Urine:Ord:Confirm | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C0802441 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine cutoff:MCnc:Pt:Urine:Qn:Screen | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C0803354 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnc:Pt:Urine:Qn:Confirm | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C0803355 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine cutoff:MCnc:Pt:Urine:Qn:Confirm | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C0942662 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnc:Pt:Milk:Qn | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C0942701 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnt:Pt:Stool:Qn | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C0943027 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnc:Pt:Vitr fld:Qn | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C0943073 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnt:Pt:Meconium:Qn | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C0945028 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnc:Pt:Ser/Plas:Qn:Confirm | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C1542996 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:PrThr:Pt:Gast fld:Ord | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C1631781 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:PrThr:Pt:Urine:Ord | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C2708816 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:SCnc:Pt:Ser/Plas:Qn | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C2924086 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnc:Pt:Ser/Plas:Qn | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C2970492 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:PrThr:Pt:Ser/Plas:Ord | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C2970493 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:PrThr:Pt:XXX:Ord | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C3173620 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine/Creatinine:MRto:Pt:Urine:Qn | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C3262477 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnt:Pt:Meconium:Qn:Confirm | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C3533429 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnc:Pt:Saliva:Qn:Confirm | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C3654081 | 3,4-Methylenedioxyamphetamine | Methylenedioxymethamphetamine+Methylenedioxyethylamphetamine+Methylenedioxyamphetamine:Imp:Pt:Urine:Ord | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C3847274 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:PrThr:Pt:Saliva:Ord:Confirm | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C3847275 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnc:Pt:Ser/Plas/Bld:Qn | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C3870286 | 3,4-Methylenedioxyamphetamine | Methylenedioxymethamphetamine+Methylenedioxyamphetamine:PrThr:Pt:Bld:Ord | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C4070695 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine cutoff:MCnc:Pt:Saliva:Qn:Confirm | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C4266167 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:MCnt:Pt:Hair:Qn | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C5452261 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:PrThr:Pt:TissCo:Ord:Screen | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000379 | has_component | C5452262 | 3,4-Methylenedioxyamphetamine | Methylenedioxyamphetamine:PrThr:Pt:TissCo:Ord:Confirm | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. | null |
C0000392 | associated_with | C0268629 | beta-alanine | Disorder of beta alanine, carnosine AND/OR homocarnosine metabolism | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | associated_with | C0523520 | beta-alanine | beta-Alanine measurement | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | The determination of the amount of beta alanine present in a sample. |
C0000392 | mapped_to | C0045356 | beta-alanine | 2,3-diaminopropionic acid | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0046514 | beta-alanine | 2-phenyl-3-aminopropanoic acid | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0047301 | beta-alanine | 3-chloroalanine | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0051360 | beta-alanine | alpha-fluoro-beta-alanine | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0067162 | beta-alanine | N(3)-(4-methoxyfumaroyl)-2,3-diaminopropionic acid | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0067265 | beta-alanine | N(beta)-fumarylcarboxyamido-2,3-diaminopropionic acid | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0067886 | beta-alanine | N-carbamoyl-beta-alanine | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0067894 | beta-alanine | N-chenodeoxycholyl-2-fluoro-beta-alanine | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0075903 | beta-alanine | technetium TC 99m 2,3-diaminopropionic acid | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0076029 | beta-alanine | technetium Tc-99m N,N'-bis(mercaptoacetyl)-2,3-diaminopropanoate | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0080655 | beta-alanine | 2,2-dimethyl-beta-alanine | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0081765 | beta-alanine | beta-naphthylalanine | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0083518 | beta-alanine | N(3)-(iodoacetyl)-2,3-diaminopropanoic acid | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0083651 | beta-alanine | N-cholyl-2-fluoro-beta-alanine | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0162893 | beta-alanine | aspartic acid-beta-4-nitroanilide | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0169614 | beta-alanine | panipenem-betamipron | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0254125 | beta-alanine | NS 11 | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0255611 | beta-alanine | CGS 24128 | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0292947 | beta-alanine | N-(2-hydroxyethyl)-N-methyl-beta-alanine | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0298717 | beta-alanine | CGP 50068 | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0298720 | beta-alanine | CGP 55461 | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0300622 | beta-alanine | N(alpha)-(tert-butyloxycarbonyl)-N(beta)-(bromoacetyl)diaminopropionic acid | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0380907 | beta-alanine | L 734217 | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0382562 | beta-alanine | benfuracarb | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | A synthetic 1-benzofuran and ethyl ester compound, and carbamate acetylcholinesterase inhibitor, that is used as a pesticide. It is characterized as a pale yellow viscous oily liquid, and exposure occurs by inhalation, ingestion, or contact. |
C0000392 | mapped_to | C0390912 | beta-alanine | 2-methyl-5-nitrophenyl-beta-alanine | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0535686 | beta-alanine | SC 57461 | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0602343 | beta-alanine | N-myristyl-beta-aminopropionate | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0605402 | beta-alanine | beta-alanine amide | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0607044 | beta-alanine | N-benzenesulfonyl-beta-alanine hydrazide | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0607969 | beta-alanine | methyl beta-alanate | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0610370 | beta-alanine | salicylidene-beta-alanine | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0619292 | beta-alanine | 2-methylene beta-alanine methyl ester | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0621569 | beta-alanine | N,N'-bis(S-benzoylmercaptoacetyl)-2,3-diaminopropionic acid ethyl ester | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0637855 | beta-alanine | insect repellent M 3535 | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0646548 | beta-alanine | N-(3-mercapto-3-methylbutyryl)-beta-alanine | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0646550 | beta-alanine | sulfosuccinimidyl-N-(3-(acetylthio)-3-methylbutyryl)-beta-alanine | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0647535 | beta-alanine | 2-methylene-beta-alanine | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0649850 | beta-alanine | N(3)-(bromoacetyl)-2,3-diaminopropanoic acid | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0649853 | beta-alanine | N(3)-(chloroacetyl)-2,3-diaminopropanoic acid | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0651645 | beta-alanine | N-(4-cyanophenyl)-N'-((sodiosulfo)methyl)urea | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0651647 | beta-alanine | N-(4-cyanophenyl)-N'-(2-carboxyethyl)urea | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0666196 | beta-alanine | L 767679 | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0674410 | beta-alanine | alaninediacetic acid | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0762137 | beta-alanine | Lys-Nva-FMDP | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0911907 | beta-alanine | DMP 745 | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0913537 | beta-alanine | SC 57101B | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C0969402 | beta-alanine | beta-alanine betaine | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C1098812 | beta-alanine | acetoxymethyl N(3)-(4-methoxyfumaroyl)-2,3-diaminopropanoate | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C1120655 | beta-alanine | 2-(4-(3-hydroxy-3-(hydroxyphenyl)propyl)-2,6-dichlorophenyl)carbomylamino-3-((thiophen-2-yl)carbonylamino)propanoic acid | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C1451693 | beta-alanine | SH 066 | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C1569207 | beta-alanine | N-(2-(5-pyridiniovaleroylthio)benzoyl)-beta-alaninamide | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C1569209 | beta-alanine | N-(2-(nicotinoylthio)benzoyl)-beta-alaninamide | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C1570247 | beta-alanine | undecyl 3-(dimethylamino)propionate | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C1685106 | beta-alanine | PC 58538 | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C1721800 | beta-alanine | 3-N-oxalyl-L -2,3-diaminopropanoic acid | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C1873149 | beta-alanine | AUY 954 | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C1957302 | beta-alanine | N-(4-((4-(1-cyclohexen-1-yl)((3,5-dichloroanilino)carbonyl)anilino)methyl)benzoyl)-2-hydroxy-beta-alanine | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C1959161 | beta-alanine | 4-(2-(3,4,5,6-tetrahydropyrimidin-2-ylamino)ethyloxy)benzoyl-2-aminoethylsulfonylamino-beta-alanine | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C1959162 | beta-alanine | 4-(2-(3,4,5,6-tetrahydropyrimidin-2-ylamino)ethyloxy)benzoyl-2-(N-(3-aminoneopenta-1-carbonyl))aminoethylsulfonylamino-beta-alanine | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C2001686 | beta-alanine | 1-(2-(1-(3-dimethylaminopropionyl)amino-2-methylpropyl)-4-methylphenyl)-4-(2-methyl-3-(4-chlorophenyl)propionyl)piperazine | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C2353995 | beta-alanine | beta-alanylcholesteryl formylhydrazide | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C2606798 | beta-alanine | 2-(2,6-dichloro-4-((3-furan-2-ylacryloylamino)methyl)benzoylamino)-3-((thiazolidine-4-carbonyl)amino)propionic acid | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C2607192 | beta-alanine | beta-alanine-arm-ICAT | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C2744498 | beta-alanine | mycmycin-1 | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C2744499 | beta-alanine | mycmycin-2 | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C2745080 | beta-alanine | XVA 143 | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C2745543 | beta-alanine | 3-(6-acetylnaphthalen-2-ylamino)-2-aminopropanoic acid | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
C0000392 | mapped_to | C2973427 | beta-alanine | methyl 3-((9-(dimethylamino)nonanoyl)(methoxy)amino)propanoate | An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.